- Harvard Medical School
- Pacific Biosciences of California Inc.
- Complete Genomics Inc.
- Gen-Probe Inc.
- Life Technologies Inc.
- Ion Torrent Systems Inc.
- 454 Life Sciences
- International Business Machines (IBM) Corp.
- Merck & Co. Inc.
- CardioDx Inc.
- GE Healthcare
- General Electric Co.
- Clarient Inc.
- Abbott Laboratories Inc.
- Avid Radiopharmaceuticals Inc.
- Eli Lilly & Co.
- Good Start Genetics Inc.
- Auxogyn Inc.
- Laboratory Corp. of America Holdings
- Exact Sciences Corp.
- Pacific Biosciences nets $186mm via its IPO
- Pacific Biosciences raises $109mm through Series F round
- IPO nets $50.2mm for Complete Genomics
- Life Technologies buys Ion Torrent for $375mm
- CardioDx gets $34.6mm through Series D venture round
- CardioDx, GE pen cardiovascular diagnostics alliance
- GE to buy Clarient for $587mm
- GE buys Abbott's POC, diagnostics units for $8bn; withdrawn
- GE acquires Amersham PLC for £5.7bn
- Eli Lilly to buy Avid for $300mm up front plus earn-outs
- Good Start Genetics brings in $18mm through its Series A round
Ask The Analyst
Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.